Loading...

Tag trends are in beta. Feedback? Thoughts? Email me at [email protected]

Bentley Systems acquires Cesium, the leader in 3D Geospatial

Half of U.S. Homeowners and Renters Struggle to Afford Their Housing Payments

Thiel Foundation Announces Next Thiel Fellow Class

FDA Designates MM120 (LSD) Breakthrough Therapy for Generalized Anxiety Disorder

1Password Acquires Kolide

Disney to invest $1.5B for an equity stake in Epic Games

Small Satellite (CubeSat) Launch Provider, Vector Space Biosciences, Announces New Drug Repurposing Platform Using Data Generated in Space

Threads Software Limited gives Meta 30 days to stop using the name Threads

Unity Announces Leadership Transition

Advanced Sweat Sensors Developed to Track Inflammatory Biomarkers in Real Time

Nissan to Adopt North American Charging Standard (NACS)

Rivian Adopts NACS and Access to Tesla’s Supercharger Network for Rivian Drivers

Dutch Consumer Group Challenges Google’s Rampant Privacy Abuse

Europe's Leading Quantum Computer Manufacturer Launches Free Online Course

Thiel Foundation Announces Next (2023) Thiel Fellow Class

Neal Stephenson's Lamina1 Launches Fund to Invest in Open Metaverse Projects

Cybercriminals Use Bots to Steal Active Pharmacy Accounts and Resell Prescriptions, Kasada's Threat Research Finds

Meta’s Dominance in the VR Market will be Challenged in the Coming Years, According to IDC

Intel Announces Initial Investment of More Than €33 Billion for Semiconductor R&D and Manufacturing in EU

PG&E and Ford Collaborate on Bidirectional Electric Vehicle Charging Technology in Customers’ Homes

Phase 3 Clinical Trial Confirms SaNOtize’s Breakthrough Treatment is 99% Effective Against COVID-19; Receives Regulatory Approval in India

Thiel Foundation announces next Thiel Fellow class: 23 entrepreneurs

Jack Dorsey's Square Changes Corporate Name To Block

Research reveals that the administration of the drug ​tofacitinib showed a 37% reduction in the risk of death and respiratory failure in patients hospitalized because of Covid-19

Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder

An Alarming 85% of Organizations Using Microsoft 365 Have Suffered Email Data Breaches, Research by Egress Reveals

OpenSourceFPGA Launches Foundation to Accelerate Adoption of Programmable Logic

Consafe Logistics Using Ada for Critical Warehouse Control System Firmware

Phase 2 data for immunotherapy drug treatment shows 0% recurrence of breast cancer after five years, 100% disease free survival for patients

Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase 1a Study of ATA188

More →